Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genelux names new president
Most recently, Devlin worked as the vice president of Abbott where she led Global Pipeline Marketing for all therapeutic areas, including oncology. Devlin held positions as vice president
Most recently, Devlin worked as the vice president of Abbott where she led Global Pipeline Marketing for all therapeutic areas, including oncology. Devlin held positions as vice president
Under the agreement, SCRI will partner with AstraZeneca to provide clinical programme development expertise, clinical programme design, medical oversight and trial management. The first clinical trial to be
Davanat is a polysaccharide polymer that targets Galectin receptors on cancer cells and interferes with their activity. Pro-Pharma has fixed the primary endpoint of the trial as the
Key Speakers– Dr. Peter Adamson, Vice President and Head of Research Ophthiris, GlaxoSmithKline– Dr. Richard Carr, Senior Director, Merck Sharp & Dohme– Dr. Hans-Jürgen Wörle, Vice President, Therapeutic
The safety and efficacy of Rhucin for the treatment of HAE attacks were evaluated in two randomized placebo-controlled studies and are supported by four open label treatment studies.
The active markets in real-time freight monitoring and tracking include high-value pharmaceuticals and life sciences, consumer electronics and computing equipment, consumer packaged goods (CPG), and general high value
Elacytarabine is a novel, patented lipid-conjugated (LVT) form of the anti-cancer drug cytarabine (Ara-C) for the treatment patients with AML and other haematological malignancies (leukaemias), which has the
OXIS claims that ErgoFlex is the only joint health complex containing the powerful antioxidant Ergothioneine (ERGO), and is specifically formulated to help the body fight the pain of
Takeda Pharma said that Leuplin was approved for CPP treatment in 1994, with a maximum allowable dosage of 90µg/kg/4 weeks. The MHLW requested Takeda to modify Leuplin’s dosage
Sun Pharma said that these generic duloxetine hydrochloride delayed-release capsules, 20mg (base), 30mg (base), and 60mg (base) are indicated in the treatment of major depressive disorder (MDD), generalised